News > Dr Reddy’s will manufacture, market Remdesivir in India
Dr Reddy’s will manufacture, market Remdesivir in India
Dr Reddy's Laboratories has entered into a non-exclusive licensing agreement with US-based Gilead Sciences to register, manufacture and sell Gilead's investigational drug Remdesivir, a potential treatment for Covid-19 , in 127 countries, including India. It will receive technology transfer from Gilead for manufacturing this drug.
Gilead Sciences has already signed 22 non-exclusive voluntary agreements with six generic pharmaceutical companies in India and Pakistan.